Molecular Plasticity Regulates Oligomerization and Cytotoxicity of the Multipeptide-length Amyloid-β Peptide Pool

Current therapeutic approaches under development for Alzheimer disease, including γ-secretase modulating therapy, aim at increasing the production of Aβ(1–38) and Aβ(1–40) at the cost of longer Aβ peptides. Here, we consider the aggregation of Aβ(1–38) and Aβ(1–43) in addition to Aβ(1–40) and Aβ(1–4...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vandersteen, Annelies, Masman, Marcelo F., De Baets, Greet, Jonckheere, Wim, van der Werf, Kees, Marrink, Siewert J., Rozenski, Jef, Benilova, Iryna, De Strooper, Bart, Subramaniam, Vinod, Schymkowitz, Joost, Rousseau, Frederic, Broersen, Kerensa
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Biochemistry and Molecular Biology 2012
Materias:
Molecular Bases of Disease
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3481277/
https://ncbi.nlm.nih.gov/pubmed/22992745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M112.394635
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares